1-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole → 3-Cyano-4-[2-(1-methyl-1h-pyrazol-5-yl)-4-(trifluoromethoxy)phenoxy]-n-1,2,4-thiadiazol-5-ylbenzenesulfonamide

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	1-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole	HCID 4912908	—
Edukt	3-cyano-N-(2,4-dimethoxybenzyl)-4-[2-iodo-4-(trifluoromethoxy)phenoxy]-N-1,2,4-thiadiazol-5-ylbenzenesulfonamide	HCID 66905795	—
Produkt	3-Cyano-4-[2-(1-methyl-1h-pyrazol-5-yl)-4-(trifluoromethoxy)phenoxy]-n-1,2,4-thiadiazol-5-ylbenzenesulfonamide	HCID 46841080	—

Reaktionsschritte

The title compound was prepared from 3-cyano-N-(2,4-dimethoxybenzyl)-4-[2-iodo-4-(trifluoromethoxy)phenoxy]-N-1,2,4-thiadiazol-5-ylbenzenesulfonamide (Preparation 497) and 1-methyl-1H-pyrazole-5-boronic acid pinacol ester using Method E above. Purification afforded the title compound.

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US08153814B2
Quelldatensatz	uspto-grants-2012_04
ORD ID	ord-d417dc54ae094ca1b9cf4157da2be2d3
Quellennotiz	uspto-grants-2012_04